Bausch Health Companies Inc
BHC
Market Cap$3.1B
Close$
$12.03
41.1% upside
Current Fair Value
41.1% upsideUndervalued by 41.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.10 Billion |
|---|---|
| Enterprise Value | $24.55 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-1.62 |
| Beta | 1.72 |
| Outstanding Shares | 360,989,744 |
| Avg 30 Day Volume | 4,136,442 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -5.24 |
|---|---|
| PEG | 5.8 |
| Price to Sales | 0.36 |
| Price to Book Ratio | -2.84 |
| Enterprise Value to Revenue | 2.8 |
| Enterprise Value to EBIT | 15.34 |
| Enterprise Value to Net Income | -42 |
| Total Debt to Enterprise | 0.91 |
| Debt to Equity | -21.91 |
Revenue Sources
No data
ESG Score
No data
About Bausch Health Companies Inc
21,100 employeesBausch Health Companies Inc. (NYSE/TSX: BHC) is a global company whose mission is to improve people's lives with our health care products. We develop, manufacture and market a range of pharmaceutical, medical device and over-the-counter ...